Minerva Surgical, Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
46/100
Weak
80
Valuation
40
Profitability
15
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UTRS research report →

52-Week Range9% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewminervasurgical.com

About the company

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA.

CEO
Darin Hammers
IPO
2021
Employees
174
HQ
Santa Clara, CA, US

Price Chart

+0.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$888
P/E
-0.00
P/S
0.00
P/B
0.00
EV/EBITDA
-1.63
Div Yield
0.00%
Profitability
Gross Margin
54.17%
Op Margin
-61.44%
Net Margin
-67.83%
ROE
-111.32%
ROIC
-54.33%
Growth & Income
Revenue
$50.29M · -3.47%
Net Income
$-34,112,000 · -58.93%
EPS
$-23.68 · -58.08%
Op Income
$-30,899,000
FCF YoY
-55.21%
Performance & Tape
52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
4.60
Avg Volume
33

Get TickerSpark's AI analysis on UTRS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 1, 23Cohen Danielother0
Feb 9, 23NEW ENTERPRISE ASSOCIATES 13 LPbuy24,437,927
Feb 9, 23Accelmed Partners II L.P.other0
Feb 9, 23Geiger Uriother0
Jan 2, 23Usen Toddother0
May 2, 22Skalnyi Evgueni V.other49,755
May 2, 22Filloux Dominique J.other60,198
May 2, 22Jung Joel Rother60,198
May 2, 22Clapper David Mother229,732
Jul 19, 22Sung Derrickother86,956
Coverage · UTRS

Our UTRS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on UTRS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate UTRS report →
Internal Compare

Similar companies

Peers in the same neighborhood.